| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $41.5M | -7.8% |
| R&D Expense | $1.6M | -29.6% |
| SG&A Expense | $14.8M | +28.5% |
| Operating Income | $20.3M | +75.0% |
| Interest Expense | $1.1M | +0.0% |
| Pre-tax Income | $20.1M | +9.5% |
| Income Tax | $22.6M | +363.7% |
| Net Income | -$2.5M | -118.8% |
| EPS (Basic) | -$0.21 | -119.3% |
| EPS (Diluted) | -$0.21 | -119.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.8M | +621.5% |
| Current Assets | $46.8M | +131.0% |
| Total Assets | $272.4M | -18.0% |
| Current Liabilities | $5.0M | -10.6% |
| Long-term Debt | $33.0M | +0.0% |
| Total Liabilities | $37.3M | -14.3% |
| Stockholders' Equity | $235.1M | -18.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.3M | +18.4% |
| Capital Expenditures | $512K | +271.0% |
| Investing Cash Flow | $68.1M | +771.6% |
| Financing Cash Flow | -$58.5M | -378.6% |
| Free Cash Flow | $26.8M | +16.9% |